CME Group Inc. (CME) operating KPIs
CMENasdaqSecurity & Commodity Brokers, Dealers, Exchanges & ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 23, 2026Score 9/3021% above fair value
$303.14+6.72 (+2.27%)
Close on Oct 30, 2026Market cap $109.00BP/E 25.7Yield 1.65%
CME cEO stock awards grant-date fair value ($)
DEF 14A Proxy Statement
Latest, FY2025
13,319,860
Period ended Dec 31, 2025
Change on a year earlier
-1.4%
13,512,333 in FY2024
History
5 years
Since FY2021
Sources
3
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | CEO stock awards grant-date fair value ($) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 13,319,860 | -1.4% | CME Group Proxy Statement (DEF 14A), filed 2026-03-23 ↗ |
| FY2024 | Dec 31, 2024 | 13,512,333 | +7.3% | CME Group Proxy Statement (DEF 14A), filed 2026-03-23 ↗ |
| FY2023 | Dec 31, 2023 | 12,594,380 | +0.5% | CME Group Proxy Statement (DEF 14A), filed 2026-03-23 ↗ |
| FY2022 | Dec 31, 2022 | 12,530,269 | +150.6% | CME Group Proxy Statement (DEF 14A), filed 2025-03-20 ↗ |
| FY2021 | Dec 31, 2021 | 5,000,000 | – | CME Group Proxy Statement (DEF 14A), filed 2024-03-18 ↗ |
Cite this data
StockData. (2026). CME CEO stock awards grant-date fair value ($), annual FY2021–FY2025 [Data set]. Compiled from CME SEC filings and investor materials. https://stockdatahq.com/stocks/cme/kpis/gov-ceo-stock
See every metric in the CME KPI table. Data updated Oct 28, 2026.